Tim Rich

Tim Rich serves as the Chief Business Officer at LabGenomics USA since August 2024. Previously, Tim held the position of Chief Executive Officer at QDx Pathology Services from May 2022 to August 2024 and served as the Chief Operations Officer at CellNetix Pathology and Laboratories from January 2019 to December 2021, overseeing laboratory operations across 29 facilities in the Northwest US. Earlier in their career, Tim was the Chief Executive Officer at PhenoPath Laboratories from September 2010 to December 2019, where responsibilities included business development, market share growth, and strategic planning. Tim also worked as VP of Sales at PatientSafe Solutions from September 2009 to July 2010. Tim holds a degree in Biochemistry from The University of Texas at Arlington, completed in December 1980.